Cargando…
Aflibercept suppresses ovarian hyperstimulation syndrome: an experimental study in rats
OBJECTIVE: In this study, we aimed to determine the impact of the antiangiogenic medications, namely, aflibercept and cabergoline in the prevention and treatment of ovarian hyperstimulation syndrome in a rat model. METHODS: A total of 36 female Wistar rats were randomly allocated to one of the five...
Autores principales: | Ateş, Çağlayan, Dilbaz, Berna, Ergani, Seval Yılmaz, Atabay, Fuad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Médica Brasileira
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610771/ https://www.ncbi.nlm.nih.gov/pubmed/37909622 http://dx.doi.org/10.1590/1806-9282.20230789 |
Ejemplares similares
-
Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?
por: Yumuşak, Ömer Hamid, et al.
Publicado: (2014) -
Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011) -
Metformin decreases the incidence of ovarian hyperstimulation syndrome: an experimental study
por: Elia, Evelin M, et al.
Publicado: (2013) -
Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015) -
Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)